Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02584933 |
|---|---|
| Brief Title: | Roll-over Study to Allow Access to Certinib (LDK378) for Patients Who Are on Ceritinib Treatment in a Novartis-sponsored Study |
| First Submitted : | October 6, 2015 |
| First Submitted that Met QC Criteria : | October 21, 2015 |
| First Posted : | October 23, 2015 (Estimate) |
| Last Update Submitted that Met QC Criteria : | November 10, 2022 |
| Last Update Posted : | November 14, 2022 |